iMDK is widely utilized in the field of biomedical research, particularly in studies focused on cancer and angiogenesis. It plays a significant role in inhibiting the growth of blood vessels, which is crucial for understanding and developing treatments for tumor progression. Researchers often employ iMDK to explore its potential in suppressing the migration and proliferation of endothelial cells, key processes in the formation of new blood vessels. Additionally, its application extends to therapeutic strategies aimed at targeting pathways involved in various cancers, making it a valuable tool in preclinical studies. The compound is also investigated for its ability to modulate signaling pathways that influence cell survival and metastasis, providing insights into novel approaches for cancer therapy.